
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodailynews.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260127T204055Z
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodailynews.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodailynews.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodailynews.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270202
DTEND;VALUE=DATE:20270203
DTSTAMP:20260910T221213Z
CREATED:20260910T221213Z
LAST-MODIFIED:20260910T221213Z
UID:10001013-1801526400-1801612799@oncodailynews.com
SUMMARY:ESSO Video-Based Workshop on Cytoreductive Surgery
DESCRIPTION:The ESSO Video-Based Workshop on Cytoreductive Surgery will take place on February 2\, 2027\, at the KARL STORZ Visitor and Training Center in Berlin\, Germany\, with online participation also available. \nThis Level 1 workshop will provide a detailed\, video-based review of cytoreductive surgery (CRS) for peritoneal surface malignancies\, covering peritoneal anatomy\, parietal and visceral peritonectomy\, PCI scoring\, minimally invasive CRS\, visceral resections\, reconstruction\, abdominal closure\, and operative reporting. \nThe programme combines surgical video demonstrations with expert discussion\, panel sessions\, and interactive Q&A\, and is aimed at senior surgical residents and experienced consultant surgeons seeking to refine their technical understanding of CRS.
URL:https://oncodailynews.com/event/cytoreductive-surgery-584057
LOCATION:KARL STORZ Visitor and Training Center Berlin\, Scharnhorststraße 3\, Berlin\, Berlin\, 10115\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/09/ChatGPT-Image-Sep-11-2026-02_02_29-AM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270203
DTEND;VALUE=DATE:20270206
DTSTAMP:20260818T161736Z
CREATED:20260818T161736Z
LAST-MODIFIED:20260818T161736Z
UID:10000934-1801612800-1801871999@oncodailynews.com
SUMMARY:ESSO Advanced Course on the Management of HIPEC after CRS
DESCRIPTION:The Advanced Course on the Management of HIPEC after CRS\, organized by the European Society of Surgical Oncology (ESSO)\, will take place on February 3–5\, 2027\, in Berlin\, Germany. \nThis Level 1 advanced course focuses on cytoreductive surgery (CRS)\, hyperthermic intraperitoneal chemotherapy (HIPEC)\, and other intraperitoneal treatments for primary and secondary peritoneal malignancies. \nThe multidisciplinary program combines evidence-based clinical decision-making with practical training\, including plenary lectures\, case discussions\, video and live demonstrations\, debates and pro/con sessions\, and a wet-lab where participants can practice open and minimally invasive cytoreductive surgery. Key topics include peritoneal surface malignancies\, colorectal and gastric cancer\, appendiceal cancer and pseudomyxoma peritonei\, mesothelioma\, ovarian cancer\, minimally invasive CRS\, and emerging approaches in peritoneal surface oncology. \nThe course is intended for senior residents\, experienced surgical oncologists\, gastrointestinal and gynecologic oncologists\, and early-career surgeons interested in peritoneal malignancies. Participants may also attend only the theoretical component\, either in person or online. Registration is currently open.
URL:https://oncodailynews.com/event/hipec-569464
LOCATION:KARL STORZ SE & Co. KG – Visitor and Training Center\, Scharnhorststrasse 3\, Berlin\, Berlin\, 10115\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-18-2026-08_14_57-PM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270204
DTEND;VALUE=DATE:20270205
DTSTAMP:20260910T225310Z
CREATED:20260910T225310Z
LAST-MODIFIED:20260910T225310Z
UID:10001014-1801699200-1801785599@oncodailynews.com
SUMMARY:World Cancer Day 2027: United by Unique
DESCRIPTION:World Cancer Day 2027\, led by the Union for International Cancer Control (UICC)\, will take place on Thursday\, February 4\, 2027\, worldwide\, with activities\, campaigns\, and events organized by cancer organizations\, healthcare institutions\, advocates\, and communities across the globe. \nThe 2027 observance continues the 2025–2027 “United by Unique” campaign\, which places people at the centre of cancer care and emphasizes that every person’s experience with cancer is different. \nThe campaign promotes people-centred cancer care\, encouraging health systems and communities to look beyond the disease and recognize each individual’s needs\, experiences\, and circumstances. Participants can take part through local events\, advocacy initiatives\, educational activities\, awareness campaigns\, and by sharing personal cancer stories.
URL:https://oncodailynews.com/event/world-cancer-day-584060
LOCATION:WorldWide
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/UI1.webp
ORGANIZER;CN="Union for International Cancer Control":MAILTO:info@uicc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270206
DTEND;VALUE=DATE:20270207
DTSTAMP:20260829T185941Z
CREATED:20260829T185941Z
LAST-MODIFIED:20260829T185941Z
UID:10000970-1801872000-1801958399@oncodailynews.com
SUMMARY:Cure to Cancer Survivorship: A New Era of Biomarkers\, Interventions\, and Care Models
DESCRIPTION:The “Cure to Cancer Survivorship: A New Era of Biomarkers\, Interventions\, and Care Models” conference will take place on February 6\, 2027\, at the Loews Atlanta Hotel in Atlanta\, Georgia. \nJointly sponsored by the Winship Cancer Institute of Emory University and Physicians’ Education Resource® (PER®)\, this inaugural one-day educational meeting will focus on integrating survivorship into cancer care from diagnosis through treatment and long-term follow-up. \nThe programme will address treatment selection and the balance between long-term efficacy\, safety\, and patient-reported outcomes; supportive physical care during and after treatment; chronic toxicities such as fatigue and nausea; long-term adherence to extended therapies; lifestyle interventions; behavioral strategies; technology-enabled tools; and shared decision-making models. \nThe meeting is designed for oncologists\, hematologists\, transplant physicians\, nurse practitioners\, physician assistants\, nurses\, and other professionals involved in the care of people with cancer. Neil M. Iyengar\, MD\, Director of Cancer Survivorship Services at Winship Cancer Institute\, serves as Program Chair.
URL:https://oncodailynews.com/event/cure-to-cancer-survivorship-577209
LOCATION:Loews Atlanta Hotel\, 1065 Peachtree Street NE\, Atlanta\, GA\, 30309\, United States
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/axj4jn42p00z-TICatalog750x3612x31.webp
ORGANIZER;CN="Physicians%E2%80%99 Education Resource%C2%AE (PER%C2%AE)":MAILTO:info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270211
DTEND;VALUE=DATE:20270214
DTSTAMP:20260804T193417Z
CREATED:20260804T193115Z
LAST-MODIFIED:20260804T193417Z
UID:10000868-1802304000-1802563199@oncodailynews.com
SUMMARY:ASCO Genitourinary (GU) Cancers Symposium 2027
DESCRIPTION:The 2027 ASCO Genitourinary (GU) Cancers Symposium\, organized by the American Society of Clinical Oncology (ASCO) and cosponsored by the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO)\, will take place on 11–13 February 2027 at Moscone West in San Francisco\, California. \nThe multidisciplinary symposium will bring together medical oncologists\, radiation oncologists\, urologists\, researchers\, advanced practice providers\, and other cancer professionals to explore cutting-edge research\, emerging treatments\, and clinical best practices across genitourinary cancers. \nThe meeting is expected to feature scientific and educational sessions\, oral abstract presentations\, poster sessions\, multidisciplinary discussions\, professional networking\, and an exhibition showcasing new technologies and innovations relevant to patient care. The complete 2027 programme\, registration information\, and abstract deadlines have not yet been announced. The official conference hashtag is GU27.
URL:https://oncodailynews.com/event/genitourinary-gu-cancers-559512
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, CA\, 94103\, United States
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-11_27_26-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270219
DTEND;VALUE=DATE:20270222
DTSTAMP:20260909T205301Z
CREATED:20260909T205301Z
LAST-MODIFIED:20260909T205301Z
UID:10001005-1802995200-1803254399@oncodailynews.com
SUMMARY:IAPCON 2027: 34th Annual International Conference of the Indian Association of Palliative Care
DESCRIPTION:The 34th Annual International Conference of the Indian Association of Palliative Care (IAPCON 2027) will take place on February 19–21\, 2027\, at the Convention Complex\, SOA University\, in Bhubaneswar\, Odisha\, India\, with pre-conference workshops scheduled for February 18. \nThe conference theme\, “Humanising High-Tech Medicine: Where Algorithm Meets Empathy\,” will explore how advances such as artificial intelligence\, precision prognostication\, regenerative therapies\, and digital health can be integrated with the core principles of dignity\, compassion\, and personalised palliative care. The programme will include scientific sessions\, keynotes\, plenaries\, debates\, workshops\, free papers\, e-posters\, and multidisciplinary participation from doctors\, nurses\, students\, therapists\, volunteers\, and other professionals involved in palliative care.
URL:https://oncodailynews.com/event/iapcon-2027-583549
LOCATION:Convention Complex\, SOA University\, Khandagiri\, SOA University\, Bhubaneswar\, Odisha\, 751030\, British Indian Ocean Territory
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/09/ChatGPT-Image-Sep-10-2026-12_52_22-AM.webp
ORGANIZER;CN="Indian Association of Palliative Care (IAPC)":MAILTO:nioiapc@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20270224T090000
DTEND;TZID=America/Halifax:20270224T170000
DTSTAMP:20260829T230210Z
CREATED:20260829T230125Z
LAST-MODIFIED:20260829T230210Z
UID:10000974-1803459600-1803488400@oncodailynews.com
SUMMARY:The 2027 Translating Evidence to Action: Elevating Cancer Care Conference
DESCRIPTION:The 2027 Translating Evidence to Action: Elevating Cancer Care conference\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place virtually on February 24\, 2027\, from 9:00 AM to 5:00 PM ET. \nDesigned for healthcare professionals across disciplines\, the annual forum focuses on translating high-quality evidence into everyday clinical practice and will feature more than 20 quality-improvement projects and practice initiatives. Project leaders will share practical strategies for implementing evidence-based change\, demonstrating measurable improvements in care\, managing change\, evaluating return on investment\, and integrating research findings into routine practice. \nFeatured speakers include Darcy Burbage\, DNP\, RN\, AOCN\, Oncology Clinical Nurse Specialist and Consulting Associate at Duke University School of Nursing\, and Ophelia Chiu\, Vice President of Strategic Innovation at MSK. The activity has been approved for AMA PRA Category 1 Credit™\, while an application for ANCC nursing contact hours is pending.
URL:https://oncodailynews.com/event/elevating-cancer-care-577380
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/1782146411582.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270225
DTEND;VALUE=DATE:20270228
DTSTAMP:20260831T145018Z
CREATED:20260829T175638Z
LAST-MODIFIED:20260831T145018Z
UID:10000969-1803513600-1803772799@oncodailynews.com
SUMMARY:31st Annual International Congress on Hematologic Malignancies
DESCRIPTION:The 31st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias\, Lymphomas\, and Myeloma\, organized by Physicians’ Education Resource® (PER)\, will take place on February 25–27\, 2027\, in Miami Beach\, Florida. \nThis in-person congress will bring together internationally recognized experts to discuss current and emerging approaches in the management of leukemias\, lymphomas\, multiple myeloma\, myelodysplastic syndromes\, and myeloproliferative neoplasms. \nThe highly interactive programme will include case-based panel discussions demonstrating how experts incorporate the latest clinical trial evidence into treatment decisions\, with particular attention to T-cell–based therapies\, targeted therapies\, antibody – drug conjugates\, and management of treatment-related toxicities. \nKeynote sessions will also explore the use of artificial intelligence in patient care and increasingly sensitive measurable residual disease (MRD) techniques in myeloma.
URL:https://oncodailynews.com/event/congress-on-hematologic-malignancies-577191
LOCATION:Eden Roc Miami Beach\, 4525 Collins Avenue\, Miami Beach\, FL\, 33140\, United States
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/vyya2zh91zj8-HEM27_WebBanners_TICatalog750x3612x.webp
ORGANIZER;CN="Physicians%E2%80%99 Education Resource%C2%AE (PER)":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20270227T070000
DTEND;TZID=America/Halifax:20270227T160000
DTSTAMP:20260901T212647Z
CREATED:20260901T212647Z
LAST-MODIFIED:20260901T212647Z
UID:10000983-1803711600-1803744000@oncodailynews.com
SUMMARY:The WAHO ASH Highlights and Insights 2027
DESCRIPTION:The WAHO ASH Highlights and Insights 2027\, organized by the Wisconsin Association of Hematology and Oncology (WAHO)\, will take place on February 27\, 2027\, from 7:00 AM to 4:00 PM CST\, at The Madison Concourse Hotel in Madison\, Wisconsin. \nThe one-day in-person programme is designed for oncology professionals who want a focused review of the most important findings from the December 2026 ASH Annual Meeting\, with expert faculty translating practice-changing clinical trial data into real-world application. \nSessions will address breakthrough trial results\, emerging treatment strategies\, and evolving standards of care across hematology and oncology\, and the event will offer continuing education credits. Provider registration is open to licensed physicians and allied health professionals working in oncology practices or universities\, as well as fellows and retirees; provider registrants must not be employed by an industry company.
URL:https://oncodailynews.com/event/waho-ash-579172
LOCATION:The Madison Concourse Hotel and Governor’s Club\, 1 West Dayton Street\, Madison\, WI\, 53703\, United States
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/09/ChatGPT-Image-Sep-2-2026-01_25_46-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270304
DTSTAMP:20260802T222653Z
CREATED:20260802T222639Z
LAST-MODIFIED:20260802T222653Z
UID:10000854-1803772800-1804118399@oncodailynews.com
SUMMARY:AACR Immuno-Oncology 2027
DESCRIPTION:AACR Immuno-Oncology 2027: Discovery and Innovation in Cancer Immunology—Revolutionizing Treatment Through Immunotherapy\, organized by the American Association for Cancer Research (AACR)\, will take place on 28 February–3 March 2027 at the JW Marriott Los Angeles L.A. Live in Los Angeles\, California. \nThe conference will bring together basic scientists\, translational researchers\, clinical investigators\, regulators\, industry professionals\, investors\, and international immuno-oncology leaders to explore advances in cancer immunology\, inflammation\, immunotherapy drugs\, immune modulators\, vaccines\, and cellular therapies. The programme will feature keynote lectures\, scientific symposia\, spotlight and educational sessions\, poster presentations\, exhibits\, and late-breaking clinical trial sessions highlighting novel agents\, treatment combinations\, and potentially practice-changing research.
URL:https://oncodailynews.com/event/aacr-immuno-oncology-557996
LOCATION:JW Marriott Los Angeles L.A. Live\, 900 West Olympic Boulevard\, Los Angeles\, CA\, 90015\, United States
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/04/AACR-congress-1.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
END:VCALENDAR